What's new? Log in Free sign up

Filing search / Centessa Pharmaceuticals plc / "Pandemic"

Search information

Centessa Pharmaceuticals plc

Companies

"Pandemic"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

60 results

Newest first Best match first

CNTA Centessa Pharmaceuticals plc

Quarterly report

the COVID-19 pandemic, researchers and CROs (including those engaged by us) experienced significant limitations in their access to animal research models … to the generation of genetically-modified rodent models used in efficacy evaluations. Prior to the pandemic, China was the leading exporter of NHPs employed

13 Aug 24

7:27am

CNTA Centessa Pharmaceuticals plc

Quarterly report

pandemic, researchers and CROs (including those engaged by us) experienced significant limitations in their access to animal research models, specifically … of genetically-modified rodent models used in efficacy evaluations. Prior to the pandemic, China was the leading exporter of NHPs employed in basic

13 May 24

4:32pm

CNTA Centessa Pharmaceuticals plc

Prospectus supplement for primary offering

and approvals; the impact of the ongoing COVID-19 pandemic, including the impact of the delta and other variants, and the impact of the Russia-Ukraine

CNTA Centessa Pharmaceuticals plc

Prospectus supplement for primary offering

-19 pandemic, including the impact of the delta and other variants, and the impact of the Russia-Ukraine war on our business and operations

CNTA Centessa Pharmaceuticals plc

programs and successfully develop our product candidates and this could result in significant harm to our business. During the COVID-19 pandemic … -modified rodent models used in efficacy evaluations. Prior to the pandemic, China was the leading exporter of NHPs employed in basic and applied research

28 Mar 24

4:44pm

jq4zu9viix7im3x

Regulation FD Disclosure

cl3p10i43ow9q6x7uhnp

Regulation FD Disclosure

Quarterly report

13 Nov 23

4:22pm

ntijcthx7h0rz ndzagc

Regulation FD Disclosure

Quarterly report

14 Aug 23

7:18am

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2023

Regulation FD Disclosure

Quarterly report

12 May 23

7:14am

ca7ekb7rw9cpz0 bt7

30 Mar 23

7:44am

ll2 2e8j8h5bxpbo

30 Mar 23

7:44am

Centessa Pharmaceuticals Reports Recent Business Progress and Financial Results for the Fourth Quarter and Full-Year 2022

Centessa Pharmaceuticals Reports Recent Business Progress and Financial Results for the Fourth Quarter and Full-Year 2022

iax5qjm1rzizp k0y

Regulation FD Disclosure

Regulation FD Disclosure

p5thqa wrcjictld

Regulation FD Disclosure

Prev
1
2
3
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.